点击公共号即可订阅
Utilities and Methods for In Vivo Bioluminescent Imaging in a CRO Laboratory
Seminar overview
The Bruker In-Vivo Xtreme systems combines multiple imaging modalities – bioluminescence, multispectal fluorescence, radioisotope imaging and X-ray – in one platform to deliver an unparalleled level of sensitivity, speed and versatility in preclinical imaging.
In this webinar, scientists at Epistem, a contract research services provider located in the UK, will be providing first-hand insight into their preclinical bioluminescent tumor cancer models and imaging workflows.
You will find out how Epistem’s scientists use bioluminescence imaging with the Bruker In-Vivo Xtreme to track cancer progression in disease models on behalf of their clients. Topics covered range from the technical aspects of producing their animal and cell models, the advantages of optical imaging, as well as how Epistem optimize their processes to overcome challenges and obtain the most accurate results.
Date
October 25th, 2016
Who should attend
This webinar will interest chief scientific officers, senior executives, directors, team leaders and senior scientists involved in the research and development of oncology drugs, including those working in the pre-clinical areas of pharmacology, research, and drug development.
Presenters
Dr. Frida Ponthan, PhD
Senior Scientist, Oncology and Preclinical Imaging, Contract Research Division Epistem Ltd (biography)
点击“阅读原文”至布鲁克官网观看回放